X
Sanofi’s Darzalex rival hits the mark in phase 3 trial
https://pharmaphorum.com/news/sanofis-darzalex-rival-hits-the-mark-in-phase-3-trial/
multiple myeloma
NICE must be reformed – Janssen UK market access chief
Janssen’s UK pricing chief Jennifer Lee has called for reform of NICE following the company’s successful but drawn-out attempt to get its cancer drug Darzalex to NHS patients.
US regulator approves new use for Amgen bone drug
New use in multiple myeloma for Xgeva
1 2
